Halliburton Company (HAL) : Holderness Investments Co reduced its stake in Halliburton Company by 1.32% during the most recent quarter end. The investment management company now holds a total of 30,807 shares of Halliburton Company which is valued at $1,350,579 after selling 412 shares in Halliburton Company , the firm said in a disclosure report filed with the SEC on Aug 12, 2016.Halliburton Company makes up approximately 1.32% of Holderness Investments Co’s portfolio.
Other Hedge Funds, Including , Freestone Capital Holdings boosted its stake in HAL in the latest quarter, The investment management firm added 501 additional shares and now holds a total of 9,611 shares of Halliburton Company which is valued at $421,346. Halliburton Company makes up approx 0.04% of Freestone Capital Holdings’s portfolio.Tweedy Browne Co reduced its stake in HAL by selling 6,683 shares or 0.13% in the most recent quarter. The Hedge Fund company now holds 5,110,577 shares of HAL which is valued at $224,047,696. Halliburton Company makes up approx 6.09% of Tweedy Browne Co’s portfolio.Eads Heald Investment Counsel boosted its stake in HAL in the latest quarter, The investment management firm added 1,605 additional shares and now holds a total of 12,115 shares of Halliburton Company which is valued at $528,941. Halliburton Company makes up approx 0.36% of Eads Heald Investment Counsel’s portfolio.Sumitomo Mitsui Asset Management Company Ltd boosted its stake in HAL in the latest quarter, The investment management firm added 1,056 additional shares and now holds a total of 65,370 shares of Halliburton Company which is valued at $2,854,054. Halliburton Company makes up approx 0.08% of Sumitomo Mitsui Asset Management Company Ltd’s portfolio.
Halliburton Company opened for trading at $44.37 and hit $45.02 on the upside on Monday, eventually ending the session at $44.74, with a gain of 0.40% or 0.18 points. The heightened volatility saw the trading volume jump to 44,74,209 shares. Company has a market cap of $38,526 M.
On the company’s financial health, Halliburton Company reported $-0.14 EPS for the quarter, beating the analyst consensus estimate by $ 0.05 according to the earnings call on Jul 20, 2016. Analyst had a consensus of $-0.19. The company had revenue of $3835.00 million for the quarter, compared to analysts expectations of $3760.48 million. The company’s revenue was down -35.2 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $0.44 EPS.
Investors should note that on Jul 14, 2016, Halliburton Company announced a cash dividend of $0.1800. The company’s management has announced Sep 2, 2016 as the ex-dividend date and fixed the record date on Sep 7, 2016. The payable date has been fixed on Sep 28, 2016.
Many Wall Street Analysts have commented on Halliburton Company. Company shares were Reiterated by FBR Capital on Jul 21, 2016 to “Outperform”, Firm has raised the Price Target to $ 53 from a previous price target of $49 .Halliburton Company was Downgraded by Societe Generale to ” Hold” on Jul 19, 2016. Company shares were Reiterated by KeyBanc Capital Mkts on Jun 21, 2016 to “Overweight”, Firm has raised the Price Target to $ 54 from a previous price target of $45 .
Halliburton Company is a provider of services and products to the upstream oil and natural gas industry. The Company operates operate under two divisions which form the basis for its two operating segments: the Completion and Production segment and the Drilling and Evaluation segment. The Companys Completion and Production segment delivers cementing stimulation intervention pressure control specialty chemicals artificial lift and completion products and services. Production Enhancement services include stimulation services and sand control services. The Companys Drilling and Evaluation segment provides field and reservoir modeling drilling evaluation and precise wellbore placement solutions. The Company conducts its business in approximately 80 countries.